Amneal Pharmaceuticals AMRX
NASDAQ AMRX
$20.30 +0.23 (+1.15%)
At close: Oct 2, 2026 · 4:00 PM EDT

Amneal Pharmaceuticals (AMRX) Cash from Operations (2017 - 2026)

Updated

Amneal Pharmaceuticals (AMRX) reported Cash from Operations of -$21.24 million for Q2 2026, compared with $83.82 million a year earlier.

Analysis

Amneal Pharmaceuticals (AMRX) Cash from Operations (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Amneal Pharmaceuticals' Cash from Operations came in at $200.78 million, down 42.8% year-over-year; for FY2025, it was $339.99 million, up 15.2% from FY2024.

  • Cash from Operations has a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
  • By year, Cash from Operations came in at $295.1 million in FY2024 (-14.6%), $345.58 million in FY2023 (+430.8%), $65.1 million in FY2022 (-73.1%) and $241.82 million in FY2021 (-36.2%).
  • Five-year quarterly Cash from Operations spans a low of -$125.52 million in Q2 2022 and a high of $141.77 million in Q3 2024.
  • Year over year, Cash from Operations gained in three of the last five quarters, with growth averaging 33.3%.
  • The high point for year-over-year Cash from Operations in five years was Q2 2025 (growth of 111.4%); the low point was Q4 2021 (a decline of 40.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$26.74 million (Q1 2026), $130.32 million (Q4 2025) and $118.45 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 8.62 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.44 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.58 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.57 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 835.00 Mn
10 Amneal Pharmaceuticals 6.48 Bn 5.76 Bn 334.51 Mn -21.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -21.24 Mn
Mar 31, 2026 -26.74 Mn
Dec 31, 2025 130.32 Mn
Sep 30, 2025 118.45 Mn
Jun 30, 2025 83.82 Mn
Mar 31, 2025 7.41 Mn
Dec 31, 2024 118.08 Mn
Sep 30, 2024 141.77 Mn
Jun 30, 2024 39.66 Mn
Mar 31, 2024 -4.41 Mn
Dec 31, 2023 135.82 Mn
Sep 30, 2023 81.39 Mn
Jun 30, 2023 -11.35 Mn
Mar 31, 2023 139.71 Mn
Dec 31, 2022 -23.29 Mn
Sep 30, 2022 93.57 Mn
Jun 30, 2022 -125.52 Mn
Mar 31, 2022 120.34 Mn
Dec 31, 2021 63.26 Mn
Sep 30, 2021 82.36 Mn
API Access

Amneal Pharmaceuticals Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=AMRX&period=max&api_key=YOUR_API_KEY